Bromide

Bromide

SCHEMBL394829

CCOC(=O)C[S+](C)C.[Br-]

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.52
MGAM O43451 1/20 0.52
SI P14410 1/20 0.52
MGAM2 Q2M2H8 1/20 0.52
ALDH1A1 P00352 3/20 0.48
TRPA1 O75762 1/20 0.48
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP1A2 P05177 1/20 0.41
ALOX15 P16050 1/20 0.40
SOAT1 P35610 1/20 0.40
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
TSHR P16473 2/20 0.35
ELANE P08246 1/20 0.34
CYP4F2 P78329 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2730412 0.97
Bromide SCHEMBL7748942 0.78 GAA (0.50) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL28204489 0.75 GAA (0.52) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL10400593 0.70
SCHEMBL10250397 0.70
Malonic Acid Diethyl Ester SCHEMBL456196 0.70 GAA (0.88) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL4499955 0.70
Malonic Acid Diethyl Ester SCHEMBL1331824 0.69 GAA (1.00) GAAMGAMSIMGAM2ALDH1A1
Ethyl Propionate SCHEMBL1332690 0.69
Ethyl Propionate SCHEMBL4883389 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12344784-B2 Stabilized perovskite quantum dot material QUANTUM ADVANCED SOLUTIONS LIMITED (GB) 2025-07-01 US claimed
US-20220064524-A1 STABILIZED PEROVSKITE QUANTUM DOT MATERIAL QUANTUM ADVANCED SOLUTIONS LIMITED (GB) 2022-03-03 US claimed
CN-113149968-A Compound serving as ketohexokinase inhibitor and application thereof 广州博济医药生物技术股份有限公司 2021-07-23 CN claimed
US-9950983-B2 Tricyclic compounds and process for preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-04-24 US claimed
US-20170233324-A1 TRICYCLIC COMPOUNDS AND PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-08-17 US claimed
WO-2016013032-A1 TRICYCLIC COMPOUNDS AND PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-01-28 WO claimed
US-8173584-B2 Composition and method for treating semiconductor substrate surface LASERWORT LTD (HK) 2012-05-08 US claimed
US-20120083436-A1 COMPOSITION AND METHOD FOR TREATING SEMICONDUCTOR SUBSTRATE SURFACE LASERWORT LTD (HK) 2012-04-05 US claimed
US-8101561-B2 Composition and method for treating semiconductor substrate surface LASERWORT LTD (HK) 2012-01-24 US claimed
US-20110118165-A1 COMPOSITION AND METHOD FOR TREATING SEMICONDUCTOR SUBSTRATE SURFACE Lee, Wai Mun (US) 2011-05-19 US claimed
EP-0877298-B1 Coated xerographic photographic paper XEROX CORP (US) 2001-08-29 EP claimed
US-6210816-B1 Translucent xerographic recording substrates XEROX CORPORATION 2001-04-03 US claimed
US-5908723-A Recording sheets XEROX CORPORATION (US) 1999-06-01 US claimed
US-5846637-A Coated xerographic photographic paper XEROX CORPORATION (US) 1998-12-08 US claimed
EP-0877298-A2 Coated xerographic photographic paper Xerox Corporation (US) 1998-11-11 EP claimed
US-4154952-A REACTING ALDEHYDES, METHYLENE COMPOUND, A SULFUR-CONTAINING HALIDE, AN INERT ORGANIC SOLVENT AND A STRONG BASE SCHULTZ HARRY W 1979-05-15 US claimed
WO-2026090317-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2026-04-30 WO disclosed
US-12435057-B2 Triazole carboxylic acids as LPA antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2025-10-07 US disclosed
EP-0021160-A1 Process for the preparation of trans-3,3-dimethyl-cyclopropane-1,2-dicarboxylic acid BAYER AG (DE) 1981-01-07 EP disclosed
US-4154952-A REACTING ALDEHYDES, METHYLENE COMPOUND, A SULFUR-CONTAINING HALIDE, AN INERT ORGANIC SOLVENT AND A STRONG BASE SCHULTZ HARRY W 1979-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12435057-B2 Triazole carboxylic acids as LPA antagonists LPAR3, LPAR1, LPAR5 GAA 1901/4885MGAM 3898/4885SI 1914/4885
US-20170233324-A1 TRICYCLIC COMPOUNDS AND PROCESS FOR PREPARATION THEREOF C1S, CYP11B1, NISCH GAA 3822/4885MGAM 4181/4885SI 1842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.